| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |